G2TT
来源类型Report
规范类型报告
DOIhttps://doi.org/10.7249/RR1527
来源IDRR-1527-BSI
Developing standards to support the synthetic biology value chain
Sarah Parks; Ioana Ghiga; Louise Lepetit; Stuart Parris; Joanna Chataway; Molly Morgan Jones
发表日期2017-09-11
出版年2017
页码108
语种英语
结论

The Synthetic Biology value chain

  • We have categorised the synthetic biology value chain into three parts: an idea of the product to be produced; the engineering steps of design, build, test repeated until the desired product is produced; and a scale-up process to produce enough product for it to be usable as a product in its own right, or within other industries.
  • The synthetic biology value chain interacts with the value chains in other sectors through i) absorption, where parts or all of the value chain of synthetic biology are used themselves within a sector-specific company, and ii) selling in, where a product is designed through synthetic biology in a company and sold into the production step of a specific sector.

Barriers

  • Economic factors, such as synthetic biology being seen as risky and expensive by investors, and social factors around possible problems of social acceptability of synthetic biology products tended to be the biggest concern of companies.
  • While barriers affect companies at all stages of the value chain, the most numerous barriers and challenges emerge at the scale-up stage of the value chain.

Standards

  • Companies think that standards will help reduce uncertainty and help to overcome a variety of barriers they encounter en-route to commercialisation. In setting standards the community needs to make sure it does not lose sight of the importance of 'soft' standards, which can facilitate norms and behaviours within the sector, as well as affect how synthetic biology is perceived by society.
摘要

The British Standards Institution asked RAND Europe to conduct a study identifying the impact that adoption of synthetic biology is likely to have on the global marketplace (buyers, sellers and users) as well as any existing barriers or obstacles preventing the rapid scale-up and commercialisation of the technology.

,

Synthetic biology can generally be thought of as a platform technology that enables the design and engineering of biologically based systems. Through a literature review and stakeholder interviews we have developed a categorisation of the synthetic biology value chain, splitting it into three parts: an idea of the product to be produced; the engineering steps of design, build, test repeated until the desired product is produced; and a scale-up process to produce enough product for it to be usable as a product in its own right, or within other industries. We identified a series of drivers that will influence the field of synthetic biology in the future, and mapped these onto the stages of the value chain. Finally we used scenarios to explore future opportunities for synthetic biology and to test the role standards might play.

,

Companies generally thought that standards will help to reduce uncertainty and overcome a variety of barriers they encounter en-route to commercialisation. In setting standards the community needs to make sure it does not lose sight of the importance of 'soft' standards, which can facilitate norms and behaviours within the sector, as well as affect how synthetic biology is perceived by society.

目录
  • Chapter One

    Introduction

  • Chapter Two

    Value chain analysis

  • Chapter Three

    Driving factors

  • Chapter Four

    Barriers and challenges for commercialisation

  • Chapter Five

    Standards in synthetic biology

  • Chapter Six

    Scenarios

  • Chapter Seven

    Conclusions

主题Biotechnology ; Emerging Technologies ; Science ; Technology ; and Innovation Policy ; United Kingdom
URLhttps://www.rand.org/pubs/research_reports/RR1527.html
来源智库RAND Corporation (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/523379
推荐引用方式
GB/T 7714
Sarah Parks,Ioana Ghiga,Louise Lepetit,et al. Developing standards to support the synthetic biology value chain. 2017.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RR1527.pdf(3144KB)智库出版物 限制开放CC BY-NC-SA浏览
1600181816398.jpg(8KB)智库出版物 限制开放CC BY-NC-SA缩略图
浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Sarah Parks]的文章
[Ioana Ghiga]的文章
[Louise Lepetit]的文章
百度学术
百度学术中相似的文章
[Sarah Parks]的文章
[Ioana Ghiga]的文章
[Louise Lepetit]的文章
必应学术
必应学术中相似的文章
[Sarah Parks]的文章
[Ioana Ghiga]的文章
[Louise Lepetit]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RR1527.pdf
格式: Adobe PDF
文件名: 1600181816398.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。